BioMarin Pharmaceuticals BMRN Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from BioMarin Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's price / book?
- BioMarin Pharmaceuticals (BMRN) reported price / book of 1.7× in Q1 2026.
- How has BioMarin Pharmaceuticals's price / book changed year-over-year?
- BioMarin Pharmaceuticals's price / book decreased by 24.9% year-over-year, from 2.3× to 1.7×.
- What is the long-term trend for BioMarin Pharmaceuticals's price / book?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's price / book has grown at a -13.7% compound annual growth rate (CAGR), from 3.9× to 1.9×.
- What does price / book mean?
- How the market price compares to the company's accounting net worth.
- How do you interpret price / book?
- Below 1.0 can flag a market discount to book value (common for distressed or asset-heavy firms); high values reflect intangible value the balance sheet doesn't capture. Most informative for financials and asset-heavy businesses.
- How does price / book compare across companies?
- A core valuation gauge for banks and insurers; weak for asset-light firms where book value understates economic value.